1zlf: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1zlf.png|left|200px]] | [[Image:1zlf.png|left|200px]] | ||
{{STRUCTURE_1zlf| PDB=1zlf | SCENE= }} | {{STRUCTURE_1zlf| PDB=1zlf | SCENE= }} | ||
===Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor=== | ===Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor=== | ||
{{ABSTRACT_PUBMED_16970402}} | {{ABSTRACT_PUBMED_16970402}} | ||
==About this Structure== | ==About this Structure== | ||
[[1zlf]] is a 2 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ZLF OCA]. | |||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:016970402</ref><references group="xtra"/> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: Dohnalek, J.]] | [[Category: Dohnalek, J.]] | ||
[[Category: Duskova, J.]] | [[Category: Duskova, J.]] | ||
| Line 32: | Line 23: | ||
[[Category: Skalova, T.]] | [[Category: Skalova, T.]] | ||
[[Category: Hiv]] | [[Category: Hiv]] | ||
[[Category: | [[Category: Hydrolase-hydrolase inhibitor complex]] | ||
[[Category: Peptidomimetic]] | [[Category: Peptidomimetic inhibitor]] | ||
[[Category: Protease]] | [[Category: Protease]] | ||
Revision as of 09:55, 26 July 2012
Crystal structure of a complex of mutant HIV-1 protease (A71V, V82T, I84V) with a hydroxyethylamine peptidomimetic inhibitor
Template:ABSTRACT PUBMED 16970402
About this Structure
1zlf is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See Also
Reference
- Skalova T, Dohnalek J, Duskova J, Petrokova H, Hradilek M, Soucek M, Konvalinka J, Hasek J. HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site. J Med Chem. 2006 Sep 21;49(19):5777-84. PMID:16970402 doi:10.1021/jm0605583
